To further verify that the synthetic lethal interaction between inhibition of de novo adenine synthesis and tumor MTAP deficiency is a pathway-specific interaction, we tested the sensitivity of MTAPdef and MTAPprof cell lines to L-alanosine, a well-known amino acid analog and a potent inhibitor of de novo adenosine monophosphate (AMP) synthesis. This evidence concerns the gene MTAP and neoplasm.